首页 | 本学科首页   官方微博 | 高级检索  
     


Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab
Authors:Bell Matthew C  Jackson Daniel J
Affiliation:1. Department of Allergology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;2. GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;3. Department of Paediatric Pulmonology and Paediatric Allergy, Beatrix Children''s Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;1. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;2. Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;3. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;4. Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;1. Cellular and Molecular Oncology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Paris Saclay, 61, Avenue du Président Wilson, Cachan Cedex 94235, France;2. Laboratory of Hematology, Pitié-Salpêtrière Hospital, 83, Boulevard de l’Hôpital, Paris 75013, France
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号